Vasculearn Network

Join our community at link in bio for insights on #bloodclots (#thrombosis) and #cardiovascular diseases such as #DVT, #PE, #afib, #diabetes, and #stroke.

[Vasculearn Network @Vasculearn]

🔥🩸 A new month = a new What's Hot in Clots! 🩸🔥

This month:

• Fatal PE among NCAA athletes
• Lipid-lowering therapies and VTE risk
• Gene-editing therapies targeting PCSK9
• Prasugrel after PCI?

Read @bbikdeli's latest synopsis 👇
https://t.co/swPjPJoqTZ

#Thrombosis #VTE #Cardiology

[Vasculearn Network @Vasculearn]

‼️ New episode of Clot, Clot, Who’s There? ‼️

In urgent bleeding, PT/aPTT and anti-Xa are often the default. But are they the right signal?

Our latest episode challenges how we assess coagulation in patients on FXa inhibitors, and what may come next.

🎧 https://t.co/vt2bQDZaTN
#Thrombosis #Hematology #Cardiology

@ESCStrokeChair

[Vasculearn Network @Vasculearn]

May’s 🔥🩸 What’s Hot in Clots 🩸🔥 just dropped!

Along with a tribute to Dr. Braunwald, @bbikdeli brings us:

• JACC spotlight on #PE + AHA/ACC guideline
• C-TRACT → benefit
• OCEANIC-STROKE → FXIa promise (?)
• V/Q SPECT → not non-inferior

👉 Read here: https://t.co/jpROjURTVV

#Thrombosis #VTE #Cardiology

[Vasculearn Network @Vasculearn]

Preventing a second stroke is still a huge unmet clinical need. Cardioembolic vs noncardioembolic. Gaps in today’s strategies. New momentum from OCEANIC-STROKE + Factor XIa.

@GBarnesMD, @mike_sharma2 , & @caso_valeria
break it all down in the latest episode of Clot, Clot, Who’s There? 🎧: https://t.co/TkI7O5nkx7

Thanks to @Bayer for supporting this episode.

@ESCStrokeChair

[Vasculearn Network @Vasculearn]

The loss of a legend who set the stage for the work that we do. He will be missed.

[Alex Spyropoulos @AlexSpyropoul]

Eugene Braunwald, ‘Icon’ of Modern Cardiology, Dies at 96 https://t.co/0ZhFX9nzuB @Vasculearn @AnticoagForum @PERTConsortium @ThrombosisUK @canvector @ThrombosisCan @EuropeanTHA @escardio

[Vasculearn Network @Vasculearn]

April’s 🔥🩸 What’s Hot in Clots 🩸🔥 is live, w/ fresh insights from @bbikdeli on a major DOAC trial and studies from #ACC26

- Apixaban vs rivaroxaban: We have a winner!
- Antiphospholipid antibodies & thrombosis: Not so rare
- HI-PEITHO: ↓ deterioration but questions remain
- LAA closure vs anticoag: Jury's still out

Dive in👉 https://t.co/ZRKzpOEGwg

#Thrombosis #VTE #ACC26

[Vasculearn Network @Vasculearn]

Patients leave appointments with questions. Clinicians leave appointments with no time.

We created the VTE Communication Guide to help bridge that gap. It highlights the key conversations clinicians should have with patients across specific timepoints in the #VTE journey.

Check it out: https://t.co/KP77YZsVax

Small tool. Big impact on communication.  Let us know what other guides you'd like to see. 💜

#bloodclotawarenessmonth

[Vasculearn Network @Vasculearn]

‼️#Antithrombotic therapy in #CAD isn’t one-size-fits-all anymore.‼️

In our latest podcast episode, @DrHeatherJohn, @tygluckman, & @DFCapodanno discuss how clinicians balance #clotting vs #bleeding risk, from aspirin’s evolving role to P2Y12 monotherapy, dual pathway inhibition, and CAD with # AF.

Less “What should everyone get?”

More “What’s right for THIS patient?”

🎧 Listen: https://t.co/9VwFysKS9W

@ESCStrokeChair #clotclotwhosthere

[Vasculearn Network @Vasculearn]

🚨 New month, new What's Hot in Clots 🚨

Special edition: @bbikdeli breaks down the recent AHA / ACC / Multisociety Acute PE Guideline: novel clinical framework + updates on Dx, risk stratification, Tx, and more.

Dive in here: https://t.co/2ZyE8hZ4Sr

#PulmonaryEmbolism #Cardiology #Hematology #Anticoagulation #Guidelines #Thrombosis

[Vasculearn Network @Vasculearn]

🎙️ New episode of Clot, Clot, Who’s There? is now live!

After successful AF ablation:

➡️ Does stroke risk persist?
➡️ Can anticoagulation ever be stopped?

🎧 Christian Ruff and @GiulioFRomiti discuss the data, patient selection, and shared decision-making...and what it all means for practice.

Listen now 👉 https://t.co/fMLvNHGACK

@ESCStrokeChair
#AtrialFibrillation #Anticoagulation #Stroke #CardioTwitter

[Alex Spyropoulos @AlexSpyropoul]

Important new guideline further refining procedural #bleed risk for #anticoagulated patients https://t.co/Q3xFTizzym @Vasculearn @AnticoagForum @PERTConsortium @thrombosisday @ThrombosisUK @ThrombosisCan @canvector @escardio @EuropeanTHA @CMichaelGibson

[Vasculearn Network @Vasculearn]

🔥🩸 The What’s Hot in Clots February issue is here! 🩸🔥

@bbikdeli covers ticagrelor + cardiac surgery (again!), age-adjusted D-dimer, natural language processing for PE detection, a cardiac metric beyond PE, and new 2026 CV stats.

Dive in: https://t.co/CtusjYMYh6

#Thrombosis #VTE #Cardiology #Hematology #ClinicalResearch

[Vasculearn Network @Vasculearn]

What’s next in AFib care? Tune into our latest episode of Clot, Clot, Who's There? to find out.

🎧 Prof. Gregory Lip chats w/ us about the major trials from 2025, post-ablation anticoagulation, & factor XI inhibitors.

Listen now: https://t.co/gIDIGAdHsI

@ThiemeIntl @ESCStrokeChair

#Cardiology #Thrombosis #Afib #MedEd #Anticoagulation

[Vasculearn Network @Vasculearn]

🔥🩸New year, new What's Hot in Clots! 🩸🔥

@bbikdeli weighs in on ticagrelor after CABG, lupus & clots, post-COVID heart risk, a surprising IVIg heart attack case, & more.

👉 https://t.co/bWcT6a1dLH

#VTE #Thrombosis #Cardiology #COVID

[Vasculearn Network @Vasculearn]

New podcast episode! 🎧 Perioperative anticoagulation made practical—when to stop, when not to bridge, and how bleeding risk drives decisions, with experts @AlexSpyropoul, James Douketis, and Marc Samama. https://t.co/fVWKbVQ0vM @TH_Journal @ThiemeIntl @ESCStrokeChair

[Vasculearn Network @Vasculearn]

New month = new edition of 🔥What's Hot in Clots🔥 from @bbikdeli

Dec. highlights:

• Global #VTE burden in the spotlight
• Another look at #antithrombotic monotherapy
• Post-MI β-blockers in normal EF
• LLMs improving VTE education
• Factor XI inhibitors: the story continues

Read more 👉 https://t.co/8W0AX1BgYH

[Vasculearn Network @Vasculearn]

🎙️ Check out our November episode of Clot, Clot, Who's There?, in partnership w/ @ThiemeIntl.

@AnticoagPharmD chats with @SCWollerMD and @VirgiSilvari about #anticoagulation stewardship—what it means, why it matters, & practical ways to improve care.

🎧 Listen now: https://t.co/sBpxUkFyik